AKRO – Knox Daily

Stock Earnings

Akero Therapeutics Inc’s filing revealed that its Chief Development Officer Yale Catriona unloaded Company’s shares for reported $0.39 million on

Stock Earnings

The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or

Insiders Updates

Akero Therapeutics Inc’s recent filing unveils that its Officer Timothy Rolph acquired Company’s shares for reported $2.0 million on May

Stock Earnings

In a filing, Akero Therapeutics Inc revealed its Chief Scientific Officer Rolph Timothy unloaded Company’s shares for reported $0.26 million

Insiders Updates

Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Akero Therapeutics

Insiders Updates

Akero Therapeutics Inc’s recently made public that its President and CEO Cheng Andrew unloaded Company’s shares for reported $1.06 million

Insiders Updates

Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Akero Therapeutics

Analysts Viewpoint

Akero Therapeutics Inc’s recently made public that its Officer PATRICK D LAMY acquired Company’s shares for reported $0.29 million on

Insiders Updates

Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Akero Therapeutics

Analysts Viewpoint

In a filing, Akero Therapeutics Inc revealed its Director Graham G. Walmsley acquired Company’s shares for reported $4.09 million on

Tag: AKRO